Medical Data Vision Co., Ltd.
3902.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥1,616 | ¥1,502 | ¥1,532 | ¥1,781 |
| % Growth | 7.5% | -2% | -14% | – |
| Cost of Goods Sold | ¥494 | ¥461 | ¥447 | ¥505 |
| Gross Profit | ¥1,121 | ¥1,041 | ¥1,086 | ¥1,276 |
| % Margin | 69.4% | 69.3% | 70.9% | 71.6% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥290 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥334 |
| SG&A Expenses | ¥1,020 | ¥1,063 | ¥1,065 | ¥842 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥508 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥1 |
| Operating Expenses | ¥1,020 | ¥1,063 | ¥1,065 | ¥1,133 |
| Operating Income | ¥101 | -¥22 | ¥21 | ¥143 |
| % Margin | 6.3% | -1.5% | 1.3% | 8% |
| Other Income/Exp. Net | ¥2 | ¥4 | ¥0 | -¥515 |
| Pre-Tax Income | ¥103 | -¥18 | ¥21 | -¥372 |
| Tax Expense | ¥38 | ¥9 | ¥8 | ¥115 |
| Net Income | ¥66 | -¥23 | ¥13 | -¥477 |
| % Margin | 4.1% | -1.5% | 0.8% | -26.8% |
| EPS | 1.73 | -0.6 | 0.33 | -12.54 |
| % Growth | 388.3% | -281.8% | 102.6% | – |
| EPS Diluted | 1.73 | -0.6 | 0.33 | -12.54 |
| Weighted Avg Shares Out | 38 | 38 | 38 | 38 |
| Weighted Avg Shares Out Dil | 38 | 38 | 38 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥2 | ¥0 | ¥1 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥28 | ¥27 | ¥26 | ¥32 |
| EBITDA | ¥131 | ¥9 | ¥47 | ¥176 |
| % Margin | 8.1% | 0.6% | 3% | 9.9% |